Article Details
Retrieved on: 2022-06-09 16:51:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Patients in the trial took dostarlimab, an immunotherapy medicine that spurs patients' immune systems to attack their cancers, every three weeks ...
Article found on: www.smithsonianmag.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here